Sign inJoin waitlistJoin the waitlist

Leona Holmberg

Professor, Clinical Research Division, Fred Hutch · University of Washington School of Medicine

Credentials: · · · · ·

History

University of Washington School of Medicine
Present
University of Washington School of Medicine
Present

Medical Oncology
1989–1991
Internal Medicine
University of Washington-Seattle Campus
1986–1989
Harvard University
Leonard M. Miller School of Medicine
1982–1986

Research

Diagnosis and Management of Multiple Myeloma: A Review
Review · JAMA · 2022 · 854 citations
Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2020 · 191 citations
High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study
Blood · 2007 · 186 citations

WB
William Bensinger
47 papers
David Maloney
39 papers
Ajay Gopal
35 papers
Hillard Lazarus
31 papers
Damian Green
28 papers
CF
Cesar Freytes
27 papers
Parameswaran Hari
24 papers
Shaji Kumar
24 papers
Richard Maziarz
20 papers
TN
Taiga Nishihori
20 papers
BW
Baldeep Wirk
19 papers
TC
Thomas Chauncey
17 papers

Clinical trials

Stem Cell Transplant to Treat Patients With Favorable or Intermediate Risk Minimal Residual Disease Negative Acute Myeloid Leukemia
Principal investigator · Withdrawn · Phase 2
Fred Hutchinson Cancer Center
2018–2022
Alternating Ixazomib Citrate and Lenalidomide as Maintenance Therapy After Stem Cell Transplant in Treating Patients With Multiple Myeloma
Principal investigator · Completed · Phase 2
Fred Hutchinson Cancer Center
2015–2025
Scleroderma Treatment With Autologous Transplant (STAT) Study
Principal investigator · Completed · Phase 2
Fred Hutchinson Cancer Center
2011–2024
Rituximab, Combination Chemotherapy, Filgrastim (G-CSF), and Plerixafor in Treating Patients With Non-Hodgkin Lymphoma Undergoing Mobilization of Autologous Peripheral Blood Stem Cells
Principal investigator · Completed · Phase 2
Fred Hutchinson Cancer Center
2010–2017